This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Oct;35(5):609-11.

doi: 10.1097/JCP.0000000000000373.

Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability

Anthony P Turel¹, Keun Hee Oh, Ian S Zagon, Patricia J McLaughlin

Affiliations

Affiliation

¹ Department of Neurology The Penn State University College of Medicine Hershey, PA Department of Neural and Behavioral Sciences The Penn State University College of Medicine Hershey, PA Department of Neural and Behavioral Sciences The Penn State University College of Medicine Hershey, PA Pxm9@psu.edu.

PMID: 26203498
DOI: 10.1097/JCP.0000000000000373

Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability

Anthony P Turel et al. J Clin Psychopharmacol. 2015 Oct.

. 2015 Oct;35(5):609-11.

doi: 10.1097/JCP.0000000000000373.

Authors

Anthony P Turel¹, Keun Hee Oh, Ian S Zagon, Patricia J McLaughlin

Affiliation

¹ Department of Neurology The Penn State University College of Medicine Hershey, PA Department of Neural and Behavioral Sciences The Penn State University College of Medicine Hershey, PA Department of Neural and Behavioral Sciences The Penn State University College of Medicine Hershey, PA Pxm9@psu.edu.

PMID: 26203498
DOI: 10.1097/JCP.0000000000000373

No abstract available

PubMed Disclaimer

Similar articles

[Naltrexone--high expectations to low dosages].
Raknes G, Giverhaug T. Raknes G, et al. Tidsskr Nor Laegeforen. 2011 May 6;131(8):844-6. doi: 10.4045/tidsskr.10.1126. Tidsskr Nor Laegeforen. 2011. PMID: 21556092 Norwegian. No abstract available.
Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis.
Roginsky G, Alexoff A, Ehrenpreis ED. Roginsky G, et al. J Clin Gastroenterol. 2015 Oct;49(9):794-5. doi: 10.1097/MCG.0000000000000398. J Clin Gastroenterol. 2015. PMID: 26280708 Clinical Trial. No abstract available.
Strategies to maximize the efficacy of naltrexone for alcohol dependence.
O'Malley SS. O'Malley SS. NIDA Res Monogr. 1995;150:53-64. NIDA Res Monogr. 1995. PMID: 8742772 No abstract available.
The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.
Patten DK, Schultz BG, Berlau DJ. Patten DK, et al. Pharmacotherapy. 2018 Mar;38(3):382-389. doi: 10.1002/phar.2086. Epub 2018 Feb 23. Pharmacotherapy. 2018. PMID: 29377216 Review.
[Low dose naltrexone for treatment of pain].
Plesner KB, Vægter HB, Handberg G. Plesner KB, et al. Ugeskr Laeger. 2015 Oct 9;177(43):V03150248. Ugeskr Laeger. 2015. PMID: 26509454 Review. Danish.

See all similar articles

Cited by

Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases.
Dara P, Farooqui Z, Mwale F, Choe C, van Wijnen AJ, Im HJ. Dara P, et al. Biomedicines. 2023 Jun 2;11(6):1620. doi: 10.3390/biomedicines11061620. Biomedicines. 2023. PMID: 37371715 Free PMC article. Review.
Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.
O'Kelly B, Vidal L, McHugh T, Woo J, Avramovic G, Lambert JS. O'Kelly B, et al. Brain Behav Immun Health. 2022 Oct;24:100485. doi: 10.1016/j.bbih.2022.100485. Epub 2022 Jul 3. Brain Behav Immun Health. 2022. PMID: 35814187 Free PMC article.
Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.
Lie MRKL, van der Giessen J, Fuhler GM, de Lima A, Peppelenbosch MP, van der Ent C, van der Woude CJ. Lie MRKL, et al. J Transl Med. 2018 Mar 9;16(1):55. doi: 10.1186/s12967-018-1427-5. J Transl Med. 2018. PMID: 29523156 Free PMC article. Clinical Trial.
Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis.
Ludwig MD, Turel AP, Zagon IS, McLaughlin PJ. Ludwig MD, et al. Mult Scler J Exp Transl Clin. 2016 Sep 29;2:2055217316672242. doi: 10.1177/2055217316672242. eCollection 2016 Jan-Dec. Mult Scler J Exp Transl Clin. 2016. PMID: 28607740 Free PMC article.
Featured Article: Serum [Met⁵]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone.
Ludwig MD, Zagon IS, McLaughlin PJ. Ludwig MD, et al. Exp Biol Med (Maywood). 2017 Sep;242(15):1524-1533. doi: 10.1177/1535370217724791. Epub 2017 Aug 2. Exp Biol Med (Maywood). 2017. PMID: 28766982 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information